Neuralink, Elon Musk's brain implant company, recently raised $600 million in a funding round that values it at $9 billion. This financial boost comes after a previous valuation of $5 billion in 2023. The company is developing medical implants aimed at aiding individuals with spinal cord injuries, demonstrated through the ability of the first patient to control devices with their brain. Neuralink also received a 'breakthrough' designation from the FDA, indicating significant potential for its technology in treating various conditions and expanding to broader applications, including telepathy.
Neuralink has ambitious plans to revolutionize brain implants, progressing from helping spinal cord injury patients to potentially offering enhancements for all, including telepathy.
The FDA granted Neuralink's implant a 'breakthrough' designation, highlighting its potential to assist individuals with disabilities while also paving the way for future applications.
Collection
[
|
...
]